Growth Metrics

908 Devices (MASS) Capital Expenditures Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.64%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 8.49%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 10.17%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 16.83%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 1.81%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2.15%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.35%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 8.08%
10 908 Devices 314.43 Mn 202.69 Mn 6.88 Mn -67.68%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -67.68%
Dec 31, 2025 -26.20%
Sep 30, 2025 -2.95%
Jun 30, 2025 19.22%
Mar 31, 2025 -36.36%
Dec 31, 2024 52.10%
Sep 30, 2024 39.07%
Jun 30, 2024 -45.03%
Mar 31, 2024 364.67%
Sep 30, 2023 47.10%
Jun 30, 2023 50.97%
Mar 31, 2023 135.27%